An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations

  • Jesse Boumelha
  • , Sophie de Carné Trécesson
  • , Emily K. Law
  • , Pablo Romero-Clavijo
  • , Matthew A. Coelho
  • , Kevin W. Ng
  • , Edurne Mugarza
  • , Christopher Moore
  • , Sareena Rana
  • , Deborah R. Caswell
  • , Miguel Murillo
  • , David C. Hancock
  • , Prokopios P. Argyris
  • , William L. Brown
  • , Cameron Durfee
  • , Lindsay K. Larson
  • , Rachel I. Vogel
  • , Alejandro Suárez-Bonnet
  • , Simon L. Priestnall
  • , Philip East
    • Sarah J. Ross, George Kassiotis, Miriam Molina-Arcas, Charles Swanton, Reuben Harris, Julian Downward

Research output: Contribution to journal › Article › peer-review

51 Scopus citations

Fingerprint

Dive into the research topics of 'An Immunogenic Model of KRAS-Mutant Lung Cancer Enables Evaluation of Targeted Therapy and Immunotherapy Combinations'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology